|
ZNF484 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.664700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.964770E-01 |
| Normal-vs-Stage2 |
1.187390E-01 |
| Normal-vs-Stage3 |
4.40099999999832E-05 |
| Normal-vs-Stage4 |
2.28209999997286E-06 |
| Stage1-vs-Stage2 |
3.785200E-01 |
| Stage1-vs-Stage3 |
3.797000E-04 |
| Stage1-vs-Stage4 |
3.56770000000672E-05 |
| Stage2-vs-Stage3 |
2.225000E-01 |
| Stage2-vs-Stage4 |
6.633800E-02 |
| Stage3-vs-Stage4 |
2.885400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.141400E-03 |
| Normal-vs-AfricanAmerican |
9.444800E-04 |
| Normal-vs-Asian |
2.792200E-01 |
| Caucasian-vs-AfricanAmerican |
1.007610E-01 |
| Caucasian-vs-Asian |
7.470100E-02 |
| AfricanAmerican-vs-Asian |
2.398100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.189800E-04 |
| Normal-vs-Female |
2.141400E-01 |
| Male-vs-Female |
3.621500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.848200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.065160E-01 |
| Normal-vs-Age(61-80Yrs) |
3.002000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.291870E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.256800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.341400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.639200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.132400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.089600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.233800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.021600E-02 |
| Normal-vs-Grade 2 |
5.099000E-01 |
| Normal-vs-Grade 3 |
3.71559999999826E-05 |
| Normal-vs-Grade 4 |
9.06010000356616E-08 |
| Grade 1-vs-Grade 2 |
9.732400E-02 |
| Grade 1-vs-Grade 3 |
1.383340E-04 |
| Grade 1-vs-Grade 4 |
4.57639999995596E-06 |
| Grade 2-vs-Grade 3 |
2.12079999999393E-05 |
| Grade 2-vs-Grade 4 |
7.49320000492659E-08 |
| Grade 3-vs-Grade 4 |
2.017600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.099600E-01 |
| Normal-vs-ccB subtype |
3.55950000000549E-05 |
| ccA subtype-vs-ccB subtype |
3.49800000076783E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.684080E-02 |
| Normal-vs-N1 |
2.011200E-04 |
| N0-vs-N1 |
1.932370E-02 |
|
|
